The optimum time for drug licensing. Market indicators

Nature Reviews Drug Discovery

Volumn 2, Issue 9, 2003, Pages 691-692

  Kalamas, James ^a   Pinkus, Gary ^a  

^a MCKINSEY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

BIOTECHNOLOGY; COMMERCIAL PHENOMENA; DRUG APPROVAL; DRUG INDUSTRY; DRUG SCREENING; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; LICENSING; NOTE; ORGANIZATION; PREDICTION; PRIORITY JOURNAL; PROCESS MODEL; PRODUCTIVITY; VALIDATION PROCESS; ARTICLE; CLINICAL TRIAL; DRUG CONTROL; ECONOMICS; HUMAN; LEGAL ASPECT; METHODOLOGY; PHARMACEUTICS; TIME;

BIOTECHNOLOGY; CLINICAL TRIALS; DRUG AND NARCOTIC CONTROL; HUMANS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 0142026201     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1181     Document Type: Note

References (0)